Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000707585 | SCV000836686 | likely benign | Severe combined immunodeficiency due to CARD11 deficiency; BENTA disease | 2025-01-13 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002492420 | SCV002777422 | uncertain significance | Severe combined immunodeficiency due to CARD11 deficiency; BENTA disease; Immunodeficiency 11b with atopic dermatitis | 2021-12-23 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004019674 | SCV004920210 | uncertain significance | Inborn genetic diseases | 2023-11-13 | criteria provided, single submitter | clinical testing | The c.2119C>T (p.R707C) alteration is located in exon 16 (coding exon 15) of the CARD11 gene. This alteration results from a C to T substitution at nucleotide position 2119, causing the arginine (R) at amino acid position 707 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Ce |
RCV004808581 | SCV005434131 | likely benign | not provided | 2024-11-01 | criteria provided, single submitter | clinical testing | CARD11: BP4 |
ITMI | RCV000120443 | SCV000084595 | not provided | not specified | 2013-09-19 | no assertion provided | reference population |